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Molecular karyotype analysis is becoming the standard tool for interrogating the genome of individuals 
with referrals of global developmental delay and 
related conditions.1,2 In this rapidly expanding field, 
the interpretation of detectable copy number losses 
and gains is becoming more challenging. We report 
here the first case of the paternal inheritance of a 
6.3 Mb interstitial deletion in 7q21 that appears to 
be associated with global developmental delay. The 
data suggest that haploinsufficiency of one or more 
genes that lie in this region may be playing a role in 
the proband’s phenotype.
Case Report
The proband, weighing 3 Kg at birth, was the 
second child of a non-consanguineous couple. His 
motor milestones were slightly delayed; he walked 
at 18 months, at which time he was also able to feed 
himself with a spoon. He said his first words soon 
after his first birthday and was combining words 
before two years of age. Challenging behaviours and 
symptoms of hyperactivity began to appear in the 
third and fourth years of life. The Conners’ Teacher 
Rating Scale, administered at 4 years of age, showed 
T-scores of 60 for conduct, 85 for hyperactivity, 66 
for inattention/passivity, and 62 for hyperactivity. 
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األثار املرتتبة على فقدان اخلنب الصبغي اجلزيئي ودور جني PCLO يف 
صعوبات التعلم 
روبرتو ل. مازت�ض، ا�شتون فريون ،�شامل اأفيتمو�ض، األي�ض م. جورج، دونالد ر. لوف.
امللخ�ص: هذا تقرير حالة ل�شبي عمره 4 �شنوات م�شاب بتاأخر التطور العام وقد مت حتويله اإىل امل�شت�شفى من اأجل عمل التنميط النووي 
وفح�ض ال�شبغ الوراثي. اأثبت الفح�ض وجود خنب �شبغي خاليل على ال�شبغ الوراثي رقم 7 يف الربطة 7q21 يف كل اخلاليا و اأظهر حتليل 
التنميط النووي اجلزيئي نتائج تف�شيلية يف 6.3 م ب خنب ال�شبغ الأحادي املحتوي على منطقة ال�شبغ الوراثي 7q21.11م ويف هذه 
املنطقة فقرية اجلينات فاإنه من املمكن اأن فقدان اأرقام ال�شنخ يف جني PCLO هو امل�شوؤول عن النمط الظاهري ال�رسيري و با�شتخدام 
حتليل ال�شبغات الوراثية بطريقة الرابطة ج لالآباء ثبت اأن هذا اجلني ال�شبغي قد ورث من الأب. وبتحليل التنميط النووي اجلزيئي لكامل 
اجلينوم لالأب ثبت اأنها متماثلة مع املوجودة يف الأبن بالرغم من اختالف النمط الظاهري لالأب والأبن. هذا اخلنب ال�شبغي الظاهر هو 
مثال اأخر لإعادة تنظيم الأ�شباغ الوراثية بالرغم من اختالف النمط الظاهري لأفراد العائلة الواحدة.
مفتاح الكلمات: بروتني PCLO؛ الب�رسي؛ النق�شان الن�شفي؛ ال�شبغ الوراثي 7؛ التثلث ال�شبغي 7q؛ نيوزيالندا؛ تقرير حالة.
abstract: We report here a 4-year-old boy with global developmental delay who was referred for karyotyping 
and fragile X studies. A small interstitial deletion on chromosome 7 at band 7q21 was detected in all cells examined. 
Subsequent molecular karyotype analysis gave the more detailed result of a 6.3 Mb heterozygous deletion involving 
the interstitial chromosome region 7q21.11. In this relatively gene-poor region, the presynaptic cytomatrix protein, 
Piccolo (PCLO) gene appears to be the most likely candidate for copy number loss leading to a clinical phenotype. 
G-banded chromosome analysis of the parents showed this deletion was inherited from the father. Molecular 
karyotype analysis of the father’s genome confirmed that it was the same deletion as that seen in the son; however, 
the father did not share the severity of his son’s phenotype. This cytogenetically-visible deletion may represent 
another example of a chromosomal rearrangement conferring a variable phenotype on different family members.
Keywords: PCLO protein, human; Haploinsufficiency; Chromosome7, trisomy 7q; Case report; New Zealand.
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He was a non-dysmorphic child with a completely 
normal physical examination, growing along the 
75th centile for height.
The proband’s 7-year-old sister had no 
behavioural or developmental problems and was 
performing at an above-average level at school. 
The proband’s father had had learning difficulties 
throughout his childhood which were referred 
to as dyslexia. He had particular difficulties in 
mathematics and English and required extra help 
and tuition. He was able to complete his high school 
studies and went on to obtain a training certificate 
and a diploma from a technical college.
Peripheral blood was taken for both routine 
G-banding and molecular karyotype analysis. In 
respect to the latter, genomic deoxyribonucleic 
acid (DNA) was isolated from the peripheral blood 
using the Gentra Puregene®  blood kit (QIAGEN 
Genomics, Bothell, Washington, USA) according 
to the manufacturer’s instructions. Using the 
Affymetrix® Cytogenetics Reagent Kit (Affymetrix, 
Santa Clara, California, USA) 0.1 micrograms of 
genomic DNA were labelled. The labelled DNA was 
applied to an Affymetrix® Cytogenetics Array (2.7 
million probes) according to the manufacturer’s 
instructions, and the array was scanned. The data 
were analysed using the Affymetrix®  Chromosome 
Analysis Suite (ChAS), Version 1.0.1 and interpreted 
with the aid of the University of California Santa 
Cruz genome browser (hg18 assembly).3
Routine G-banded chromosome analysis was 
undertaken in duplicate for the proband and 
his parents, which identified a subtle interstitial 
deletion in the long arm of one chromosome 7, both 
in the proband and his father [Figure 1] 46,XY,del(7)
(q21.1q21.1). Molecular karyotype analysis of 
the proband confirmed a 6.3 Mb interstitial 
heterozygous deletion in the chromosome region 
7q21.11 (hg18 coordinates chr7: 79,573,975-
85,833,865) [Figure 2], as well as a 458 kb terminal 
duplication in the chromosome region Xp22.33 
(hg18 coordinates chrX:858,113-1,316,852). This 
terminal X chromosome region carries the CRFL2 
gene (cytokine receptor-like factor 2), which is a 
receptor for thymic stromal lymphopoietin and so 
would not appear to play any role in the phenotype 
of the proband. Molecular karyotyping of the father 
 
Figure 1 Panels A–C: Partial karyotype and ideograms 
of chromosomes 7 of proband and father. Panel A: 
The homologous chromosomes 7 from two metaphase 
spreads (M1 and M2) of the proband. Panel B: The 
homologous chromosomes 7 from two metaphase 
spreads (M1 and M2) of the proband’s father. Panel 
C: An ideogram of the location of the deletion on 
chromosome 7 (left), and a normal chromosome 7 
(right).
 
Figure 2 Panels A&B: Schematic of the chromosome 7 region that is deleted in the proband. Panel A: Ideogram of 
chromosome 7, together with the location and extent of the deletion detected in the proband (7q21.11; hg18 coordinates 
chr7: 79,573,975-85,833,865; boxed in red). Panel B: Shows the Refseq genes that are localised to the deleted region, 
those genes that are curated in the Online Mendelian Inheritance in Man (OMIM) database4 and cases reported in the 
DECIPHER database.13 The images were taken from the UCSC genome browser.3
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showed the same 6.3 Mb heterozygous deletion 
in 7q21.11 (hg18 coordinates chr7:79,573,967-
85,835,041); the small X chromosome duplication 
event detected in the proband was not found in 
the father. The 6.3 Mb deletion was not detected in 
the paternal grandparents of the proband; hence, 
the deletion arose de novo in the father. Table 1 
summarises the genes that are localised to the 
chromosome 7 region which were deleted in the 
proband.
Discussion
The deleted region of chromosome 7 encompasses 
10 genes [Table 1]. Of these, the Online Mendelian 
Inheritance in Man (OMIM)4 database shows that 
3 are disease-causing: OMIM 173510 (platelet 
glycoprotein IV deficiency), OMIM 142409 (hepatic 
growth factor), and OMIM 608166 (semaphorin 3E/ 
coloboma, heart defect, atresia choanae, retarded 
growth and development, genital abnormality, and 
ear abnormality [CHARGE] syndrome). In terms 
of the latter, disruption of, or mutations in, the 
SEMA3E gene are rare in patients with CHARGE 
syndrome, which is associated with mental 
retardation but usually occurs in combination with 
eye defects (coloboma) and heart anomalies that 
were not detected in the case reported here.5 Only 
one CHARGE patient has been described with 
a mutation in the SEMA3E gene, and this was a 
missense mutation resulting in a serine to leucine 
substitution at amino acid position 243.5 Of the 
Table 1: Genes that lie in the chromosome 7 region: 79,573,975-85,833,865 (hg18 coordinates)
Gene Protein OMIM Description
GNAI1 Guanine nucleotide binding protein G(i) 
subunit alpha-1
139310 The encoded protein is part of a complex that 
responds to beta-adrenergic signals by inhibiting 
adenylate cyclase.
CD36 CD36 molecule (thrombospondin receptor) 173510 This protein may have important functions as a 
cell adhesion molecule. Mutations in this gene 
cause platelet glycoprotein deficiency.
SEMA3C Semaphorin 3C 602645 This protein is a non-multidrug resistance gene 
of human cancers
HGF Hepatocyte growth factor (hepapoietin A; 
scatter factor)
142409 Hepatocyte growth factor regulates cell growth, 
cell motility, and morphogenesis by activating a 
tyrosine kinase signaling cascade after binding 
to the proto-oncogenic c-Met receptor.
CACNA2D1 Voltage-dependent calcium channel subunit 
alpha-2/delta-1
114204 This gene encodes a member of the alpha-2/
delta subunit family, which is a protein in the 
voltage-dependent calcium channel complex.
PCLO Piccolo (presynaptic cytomatrix protein) 604918 The protein encoded by this gene is part of 
the presynaptic cytoskeletal matrix, which is 
involved in establishing active synaptic zones 
and in synaptic vesicle trafficking. Variations 
in this gene have been associated with bipolar 
disorder and major depressive disorder.
SEMA3E Semaphorin 3E 608166 Semaphorins serve as axon guidance ligands via 
multimeric receptor complexes. Screening of 
patients with CHARGE syndrome for mutations 
in the SEMA3E gene revealed a de novo missense 
mutation in an unrelated patient.
SEMA3A Semaphorin 3A 603961 This secreted protein can function as either 
a chemorepulsive agent, inhibiting axonal 
outgrowth, or as a chemoattractive agent, 
stimulating the growth of apical dendrites. 
In both cases, the protein is vital for normal 
neuronal pattern development. Increased 
expression of this protein is associated with 
schizophrenia.
SEMA3D Semaphorin 3D 609907 Knockdown of the zebrafish orthologue of 
semaphorin 3D (SEMA3D) reduces the number 
of peripheral axons, and expression in the chick 
suggests that this protein may play an important 
role in heart development.
OMIM = Online Mendelian Inheritance in Man; CHARGE = coloboma, heart defect, atresia choanae, retarded growth and development, genital 
abnormality, and ear abnormality.
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remaining genes located in the deleted region, the 
presynaptic cytomatrix protein, Piccolo (PCLO), 
gene appears to be a likely candidate to be associated 
with developmental delay.
The PCLO gene expresses Piccolo (presynaptic 
cytomatrix protein) which is a component of the 
presynaptic cytoskeletal matrix that is involved in 
maintaining the neurotransmitter release site in 
register with the postsynaptic reception apparatus.6–9 
Piccolo appears be involved in the cycling of 
synaptic vesicles at presynaptic nerve terminals of 
glutamatergic and gamma aminobutyric acid-ergic 
(GABAergic) central nervous system synapses.
Overexpression of the PCLO gene has been 
implicated in bipolar/mood disorders in humans.10 
Interestingly, knockdown studies in mice show that 
Piccolo controls the extracellular levels of glutamate 
in the hippocampus when stimulated, and appears 
to play a pivotal role in synaptic plasticity in area 
CA1 and in hippocampus-dependent learning.11 
It is tempting to speculate that the semaphorin 
genes that are localised to the deleted chromosome 
7 region may also play a role, together with the 
PCLO gene, in the proband’s phenotype. The 
semaphorins have roles in axonal guidance and 
haploinsufficiency for these proteins may affect 
normal brain development; however, animal 
modelling data are limited in terms of heterozygous 
knockdown studies of these genes. At least for 
semaphorin 3C, targeted disruption of the mouse 
orthologue leads to cardiovascular defects although 
only in the homozygous state; heterozygous mice are 
indistinguishable from their wild-type littermates.12
Significantly, the Database of Chromosomal 
Imbalance and Phenotype in Humans Using 
Ensembl Resources (DECIPHER) database13 
contains two patients’ entries, cases 854 and 
855 carrying deletions of 35.4 Mb and 17 Mb, 
respectively, that largely overlap the region identified 
in the case reported here; these patients exhibited a 
developmental delay/mental retardation phenotype. 
In addition, Courtens et al. reported a patient with 
moderate developmental delay and mild dysmorphic 
features with maternal monosomy in chromosome 
7q21 (between 75.82 Mb and 92.59 Mb).14 Also of 
relevance is the almost complete absence of large 
genomic variation among unaffected individuals 
within this region of chromosome 7 suggesting that 
copy-number variations (CNVs) in this region are 
not benign.
If Piccolo contributed to the phenotype 
observed in our case study, then a number of 
mechanisms might explain why the same deletion 
that was present in the proband’s father resulted 
in a less severe clinical phenotype. Clinical 
variability may be due to a two hit model, or allele-
specific expression.15,16 In respect of the former, an 
additional CNV, or a mutation below our detection 
threshold, may underlie differing clinical severity. 
In respect of the latter, it is unclear if there are 
parent-of-origin expression differences of the PCLO 
gene. Interestingly, imprinting of chromosome 7 
is well-documented, but appears to be limited to 
those genes that lie distally in 7q23.1.17–19 This case 
represents another example of a chromosomal 
rearrangement conferring a variable phenotype on 
different family members.20
Conclusion
This rare case is the first to report a small but 
detectable interstitial deletion in 7q11.23 that is 
paternally-inherited and appears to be implicated 
in developmental delay. Haploinsufficiency of the 
PCLO gene seems to be the most likely explanation 
for the clinical phenotype. Further cases of deletions 
that lie in this region of chromosome 7 should 
help confirm the role of Piccolo in developmental 
delay, and the mechanism underpinning clinical 
variability.
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